Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 20 peer-reviewed journal articles Updated
Dermatology

Identifying CLE Subtypes and Symptoms

At a Glance

Cutaneous lupus erythematosus (CLE) is categorized into main subtypes: acute, subacute, and chronic (discoid) lupus. Identifying your specific subtype is crucial because it determines your risk for permanent scarring, hair loss, and the likelihood of developing systemic lupus (SLE).

Identifying the specific subtype of Cutaneous Lupus Erythematosus (CLE) is the most important step in predicting how the disease will behave and whether it will leave lasting marks on your skin. Doctors use a combination of clinical appearance, location, and biopsy results to categorize CLE into three primary types—Acute, Subacute, and Chronic—as well as rarer forms that affect deeper tissues [1][2].

The CLE Subtype Matrix

Each subtype has a “signature” look and a different relationship with Systemic Lupus Erythematosus (SLE).

Subtype Primary Appearance Risk of Systemic Lupus (SLE) Scarring Potential
Acute (ACLE) “Butterfly” rash on face; flat or raised red patches [3] Very High [4] Low (Non-scarring) [3]
Subacute (SCLE) Ring-shaped (annular) or scaly (psoriasis-like) patches [5] Moderate [6] Low (Non-scarring) [7]
Chronic (DLE) Thick, disc-shaped scaly plaques; “follicular plugging” [8] Low to Moderate [8] High (Permanent scarring) [8]

Acute Cutaneous Lupus (ACLE) and the “Butterfly Rash”

The most famous symptom of ACLE is the malar rash, commonly known as the butterfly rash [3]. It typically appears as a red or pinkish-violet eruption across the bridge of the nose and the cheeks [3]. A key identifying feature is that it usually spares the nasolabial folds (the creases running from the nose to the corners of the mouth) [9]. ACLE is almost always a sign of active systemic lupus [4]. While it can be distressing, the good news is that these lesions do not typically cause permanent scarring [10].

Subacute Cutaneous Lupus (SCLE)

SCLE often presents as red, scaly patches that look like psoriasis, or as circular, ring-shaped lesions (annular) [5]. These appear most often in sun-exposed areas like the chest, upper back, and arms [11]. Unlike chronic forms, SCLE is non-scarring, meaning that once the inflammation is controlled, the skin usually returns to its normal texture, though some temporary color changes (pigmentation) may remain [7]. Notably, SCLE can sometimes be triggered by medications, such as certain blood pressure drugs or acid reflux medications [12].

Chronic Cutaneous Lupus: Discoid Lupus (DLE)

Discoid Lupus is the most common form of chronic skin lupus [8]. It gets its name from the disc-shaped (discoid) plaques it creates [13]. These lesions frequently appear on the scalp, inside the ears, and on the face or neck [8]. They are often thick and scaly and can cause follicular plugging, where the hair follicles become blocked [14].

  • Scarring and Atrophy: DLE is uniquely aggressive in its ability to cause permanent, fibrotic scarring and atrophy (thinning of the skin) [7].
  • Hair Loss: When DLE occurs on the scalp, it can cause scarring alopecia, which is permanent hair loss because the hair follicles are destroyed by inflammation [15][10]. Early treatment is essential to prevent permanent damage [15].

Lupus Panniculitis: The Deep Form

Lupus Erythematosus Panniculitis (LEP), also known as lupus profundus, is a rarer form that affects the subcutaneous fat (the layer of fat beneath the skin) [16]. Instead of a surface rash, it presents as firm, tender nodules or lumps under the skin, often on the arms, legs, or buttocks [16][17]. When these nodules heal, they often leave behind “saucerized” depressions—permanent dents in the skin where the fat has been destroyed (lipoatrophy) [18][14].

Tracking Your Skin Changes

Because subtypes can overlap or change over time, keeping a “skin diary” is highly effective for your care team.

  • Note the Timing: Track when the flare appeared relative to sun exposure or medication changes, as UV-induced flares can sometimes take weeks to show up [19].
  • Note the Location: Is the rash only on sun-exposed areas?
  • Check the Texture: Is it flat and smooth (ACLE), scaly (SCLE/DLE), or thick and hard (DLE)?
  • Watch the Healing: When a spot goes away, is the skin smooth, or is there a scar or a “dent”?
  • Photo Documentation: Take clear, well-lit photos of new lesions to show your dermatologist, as rashes can change or fade before your appointment [20].

Common questions in this guide

Does having a skin lupus rash mean I have systemic lupus?
The risk depends on your specific subtype. Acute cutaneous lupus (ACLE) is almost always linked to active systemic lupus, while chronic forms like discoid lupus (DLE) have a much lower risk of involving your internal organs.
Will my lupus rash leave a permanent scar?
Acute and subacute lupus rashes generally do not cause permanent scarring once they heal. However, chronic forms like discoid lupus can cause permanent fibrotic scarring and skin thinning if not treated early.
Can skin lupus cause permanent hair loss?
Yes, if discoid lupus develops on the scalp, it can cause a condition called scarring alopecia. Severe inflammation can permanently destroy the hair follicles, which makes early treatment essential to prevent permanent bald patches.
Can medications cause a lupus rash?
Yes, certain medications, including specific blood pressure drugs and acid reflux medications, can trigger subacute cutaneous lupus (SCLE). If you develop ring-shaped or scaly rashes, your doctor will likely review your current prescriptions.
What are the deep lumps under my skin?
Lupus panniculitis is a rare, deeper form of skin lupus that inflames the fat layer beneath the skin. Instead of a surface rash, it creates firm, tender lumps that can leave permanent dents or depressions in the skin when they heal.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Based on the appearance and biopsy of my skin, which specific subtype of CLE do I have?
  2. 2.Is there evidence of 'follicular plugging' or scarring that might lead to permanent hair loss?
  3. 3.Does the distribution of my rash suggest a strong link to systemic lupus (SLE)?
  4. 4.If my subtype is SCLE, could any of my current medications be the underlying cause?
  5. 5.Are the deep lumps I'm feeling consistent with lupus panniculitis?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (20)
  1. 1

    Cutaneous lupus erythematosus - from pathogenesis to targeted therapy.

    Klein B, Billi AC, Abernathy-Close L, Kahlenberg JM

    Nature reviews. Rheumatology 2025; (21(12)):703-718 doi:10.1038/s41584-025-01318-6.

    PMID: 41204012
  2. 2

    Current Concepts on Pathogenic Mechanisms and Histopathology in Cutaneous Lupus Erythematosus.

    Fetter T, Braegelmann C, de Vos L, Wenzel J

    Frontiers in medicine 2022; (9()):915828 doi:10.3389/fmed.2022.915828.

    PMID: 35712102
  3. 3

    Autoimmune Skin Conditions: Cutaneous Lupus Erythematosus.

    Foulke G, Helm LA, Clebak KT, Helm M

    FP essentials 2023; (526()):25-36.

    PMID: 36913660
  4. 4

    The role of TNF-α as a potential marker for acute cutaneous lupus erythematosus in patients with systemic lupus erythematosus.

    Jinshan Z, Yong Q, Fangqi C, et al.

    The Journal of dermatology 2024; (51(11)):1481-1491 doi:10.1111/1346-8138.17355.

    PMID: 38963308
  5. 5

    Three cases of subacute cutaneous lupus erythematosus associated with malignancy: a late paraneoplastic phenomenon.

    Xie F, Frewen J, Divekar P

    Clinical and experimental dermatology 2020; (45(5)):607-608 doi:10.1111/ced.14176.

    PMID: 31944366
  6. 6

    [Lupus erythematosus].

    Strunz PP, Schmalzing M, Goebeler M, Schmieder A

    Dermatologie (Heidelberg, Germany) 2025; (76(9)):582-600 doi:10.1007/s00105-025-05554-5.

    PMID: 40888883
  7. 7

    Microarray study reveals a transforming growth factor-β-dependent mechanism of fibrosis in discoid lupus erythematosus.

    Solé C, Gimenez-Barcons M, Ferrer B, et al.

    The British journal of dermatology 2016; (175(2)):302-13 doi:10.1111/bjd.14539.

    PMID: 26972571
  8. 8

    Persistent red and swollen eyelids.

    Maya Y, Tashimo A, Ota M

    Lancet (London, England) 2018; (392(10157)):1552 doi:10.1016/S0140-6736(18)32327-4.

    PMID: 30496061
  9. 9

    Successful treatment of facial systemic lupus erythematosus lesions with Dr Michaels® (Soratinex®) product family. A case report.

    Tirant M, Bayer P, Hercogovấ J, et al.

    Journal of biological regulators and homeostatic agents 2016; (30(2 Suppl 3)):95-102.

    PMID: 27498665
  10. 10

    Sex-based clinical and immunological differences across lupus erythematosus subtypes: a cross-sectional multicentre study from China.

    Pan Y, Jin H, Zhou S, et al.

    Lupus science & medicine 2026; (13(1)) doi:10.1136/lupus-2025-001783.

    PMID: 41730565
  11. 11

    Voriconazole-Induced Subacute Cutaneous Lupus Erythematosus in an Adult With Aspergillosis.

    Ezra N, Jourabchi N, Mousdicas N

    Skinmed 2016; (14(6)):461-463.

    PMID: 28031137
  12. 12

    Proton pump inhibitors-related subacute cutaneous lupus erythematosus: Clinical characteristics, management, and outcome.

    Deng Z, Guo A, Wu C, Wang C

    Journal of cosmetic dermatology 2022; (21(12)):7202-7208 doi:10.1111/jocd.15450.

    PMID: 36214602
  13. 13

    Topical niacinamide (Nicotinamide) treatment for discoid lupus erythematosus (DLE): A prospective pilot study.

    Nouh AH, Elshahid AR, Kadah AS, Zeyada YA

    Journal of cosmetic dermatology 2023; (22(5)):1647-1657 doi:10.1111/jocd.15628.

    PMID: 36683259
  14. 14

    Lupus Erythematosus Profundus with Multiple Overlying Cutaneous Ulcerations: A Rare Case.

    Sutedja E, Widjaya MRH, Dharmadji HP, et al.

    Clinical, cosmetic and investigational dermatology 2023; (16()):2721-2726 doi:10.2147/CCID.S430068.

    PMID: 37790903
  15. 15

    Clinical recognition and management of alopecia in women of color.

    Raffi J, Suresh R, Agbai O

    International journal of women's dermatology 2019; (5(5)):314-319 doi:10.1016/j.ijwd.2019.08.005.

    PMID: 31909150
  16. 16

    Clinical Characteristics of Lupus Erythematosus Panniculitis/Profundus: A Retrospective Review of 61 Patients.

    Rangel LK, Villa-Ruiz C, Lo K, et al.

    JAMA dermatology 2020; (156(11)):1264-1266 doi:10.1001/jamadermatol.2020.2797.

    PMID: 32876656
  17. 17

    Pediatric-Onset Refractory Lupus Erythematosus Panniculitis Treated With Rituximab.

    Angra D, Roehrs PA, Googe PB, Adamson AS

    Cutis 2021; (108(2)):E44-E46 doi:10.12788/cutis.0351.

    PMID: 34735333
  18. 18

    Permanent Injectable Polyacrylamide Hydrogel Dermal Filler for a Large Subcutaneous Defect Secondary to Lupus Panniculitis.

    Gupta K, Bhari N, Verma KK, Gupta S

    Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] 2017; (43(1)):152-154 doi:10.1097/DSS.0000000000000839.

    PMID: 27399948
  19. 19

    Cutaneous lupus erythematosus: clinico-pathologic correlation.

    Filotico R, Mastrandrea V

    Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia 2018; (153(2)):216-229 doi:10.23736/S0392-0488.18.05929-1.

    PMID: 29368845
  20. 20

    Can Dermoscopy Be a Useful Follow-Up Tool in Patients with Discoid Lupus Treated with Anifrolumab?

    Ambrogio F, Foti C, Noviello S, et al.

    Diagnostics (Basel, Switzerland) 2025; (15(5)) doi:10.3390/diagnostics15050522.

    PMID: 40075770

This page provides educational information about cutaneous lupus erythematosus (CLE) subtypes and symptoms. Always consult your dermatologist or rheumatologist for an accurate diagnosis and personalized medical advice.

Get notified when new evidence is published on Cutaneous lupus erythematosus.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.